This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Chubb Limited was formerly known as ACE Limited. ACE Limited after acquiring The Chubb Corp in Jan 2016 assumed the name of Chubb. Headquartered in Zurich, Switzerland, the company boasts being one of the world’s largest providers of property and casualty (P&C) insurance and reinsurance and largest publicly traded P&C insurer, based on market capitalization of $56.9 billion. Chubb has diversified through acquisitions into many specialty lines, including marine, medical risk, excess property, environmental and terrorism insurance and has local operations in 54 countries and territories. Chubb provides specialized insurance products such as personal accident, supplemental health and life insurance to individuals in select countries. Its reinsurance operations include both P&C and life companies.
Should Value Investors Buy Chubb Limited (CB) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Reasons Why Investors Should Retain Chubb Limited (CB) Stock
by Zacks Equity Research
Chubb Limited (CB) stands to gain from improving rate environment, expanding underwriting margins, strategic acquisitions and effective capital deployment.
Will Chubb (CB) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Chubb (CB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Zacks Analyst Blog Highlights Novo Nordisk, AstraZeneca, Accenture, Chubb and Roper Technologies
by Zacks Equity Research
Novo Nordisk, AstraZeneca, Accenture, Chubb and Roper Technologies are part of the Zacks top Analyst Blog.
Top Research Reports for Novo Nordisk, AstraZeneca & Accenture
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), AstraZeneca PLC (AZN) and Accenture plc (ACN).
Chubb (CB) is a Top-Ranked Value Stock: Should You Buy?
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Should You Invest in the iShares U.S. Insurance ETF (IAK)?
by Zacks Equity Research
Sector ETF report for IAK
CNA Financial (CNA) Up 0.1% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
CNA Financial (CNA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should You Invest in the Invesco KBW Property & Casualty Insurance ETF (KBWP)?
by Zacks Equity Research
Sector ETF report for KBWP
Why Is Everest Re (RE) Up 9% Since Last Earnings Report?
by Zacks Equity Research
Everest Re (RE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Chubb (CB) Up 4.9% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Chubb (CB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Chubb (CB) Stock Up 8% YTD: Will the Bull Run Continue?
by Zacks Equity Research
A compelling portfolio, strong renewal retention, positive rate increases, strategic initiatives to fuel profitability and solid capital position continue to drive Chubb (CB).
Insurance ETFs Rallying on Solid Q3 Earnings
by Sweta Killa
A slew of solid earnings from the leading players in the insurance industry added to the strength as some of the prominent players surpassed estimates for both earnings and revenues.
CNO Financial (CNO) Up on Q3 Earnings Beat, Revenues Down Y/Y
by Zacks Equity Research
CNO Financial's (CNO) third-quarter results reflect improved annuity collected premiums and lower benefits and expenses. Management expects higher sales in 2022.
Aflac's (AFL) Q3 Earnings Beat on Lower Benefits and Expenses
by Zacks Equity Research
Aflac's (AFL) third-quarter results reflect reduced net benefits and claims, partly offset by lower net investment income and soft revenues in both businesses.
Zacks Industry Outlook Highlights Berkshire Hathaway, Chubb, The Progressive, W.R. Berkley and ProAssurance
by Zacks Equity Research
Berkshire Hathaway, Chubb, The Progressive, W.R. Berkley and ProAssurance are part of the Zacks Industry Outlook article.
Hartford Financial (HIG) Beats on Q3 Earnings, Hikes Dividend
by Zacks Equity Research
Hartford Financial's (HIG) third-quarter results reflect better P&C earned premium and lower excess mortality losses. A 10% hike in quarterly dividend remains noteworthy.
5 Property & Casualty Insurers to Gain Despite Industry Challenges
by Tanuka De
Frequent catastrophes accelerating policy renewal rate and the resultant upward pricing pressure are likely to boost the performance of Zacks Property and Casualty Insurance industry players like BRK.B, CB, PGR, WRB and PRA.
Chubb (CB) Q3 Earnings Top Estimates on Higher Earned Premium
by Zacks Equity Research
Chubb's (CB) Q3 results reflect record investment results and underwriting income and premium revenue growth across all the segments.
Chubb (CB) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Chubb (CB) delivered earnings and revenue surprises of 4.97% and 3.21%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
RLI Q3 Earnings Top Estimates, Decline Y/Y on High Cat Loss
by Zacks Equity Research
RLI's Q3 results reflect solid performance across all its segments and favorable reserve development, and higher net investment income, affected by losses stemming from Hurricane Ian.
Chubb's (CB) Q3 Earnings Coming Up: What's in the Cards?
by Zacks Equity Research
Chubb's (CB) Q3 earnings are likely to reflect higher premiums and improved net investment income, offset by higher expenses.
Travelers' (TRV) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Travelers' (TRV) Q3 earnings reflect higher net written premiums, improved combined ratio and higher underwriting gain, partially offset by lower net investment income and higher expenses.
Arch Capital Group (ACGL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Arch Capital (ACGL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Should You Add Chubb (CB) Stock to Your Portfolio
by Zacks Equity Research
A compelling portfolio, strong renewal retention, positive rate increases, strategic initiatives to fuel profitability and solid capital position poise Chubb (CB) for growth.